Chengxun Li

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Antibody-DNA nanostructure conjugate enables targeted delivery of gemcitabine to tumor and improves the anti-tumor efficacy
  Journal of Controlled Release 2025 DOI: 10.1016/j.jconrel.2025.113613
  +Save
• Establishment and molecular characterisation of patient-derived organoids for primary central nervous system lymphoma
  Leukemia 2025 DOI: 10.1038/s41375-025-02562-1
  +Save
• Cholesterol‐Modified DNA Nanostructures Serve as Effective Non‐Viral Carriers for Delivering siRNA to the Kidneys to Prevent Acute Kidney Injury
  Small 2024 DOI: 10.1002/smll.202311690
  +Save
• Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
  Chengxun Li, Jiale Zhang, Qiming Wu +3 more
  Molecular Cancer Therapeutics 2023 DOI: 10.1158/1535-7163.MCT-22-0159
  +Save
• Target identification of a novel unsymmetrical 1,3,4‐oxadiazole derivative with antiproliferative properties
  Journal of Cellular Physiology 2021 DOI: 10.1002/jcp.30120
  +Save
• Crystal structure of 6,7-dihydroxy-6,7-dihydro-3H-imidazo[1,2-a]purin-9(5H)-one
  Acta Crystallographica Section E Crystallographic Communications 2016 DOI: 10.1107/s2056989016009087
  +Save